Literature DB >> 27026638

Animal behavioral assessments in current research of Parkinson's disease.

Tetsuya Asakawa1, Huan Fang2, Kenji Sugiyama3, Takao Nozaki3, Zhen Hong4, Yilin Yang5, Fei Hua5, Guanghong Ding6, Dongman Chao7, Albert J Fenoy7, Sebastian J Villarreal7, Hirotaka Onoe8, Katsuaki Suzuki9, Norio Mori9, Hiroki Namba3, Ying Xia10.   

Abstract

Parkinson's disease (PD), a neurodegenerative disorder, is traditionally classified as a movement disorder. Patients typically suffer from many motor dysfunctions. Presently, clinicians and scientists recognize that many non-motor symptoms are associated with PD. There is an increasing interest in both motor and non-motor symptoms in clinical studies on PD patients and laboratory research on animal models that imitate the pathophysiologic features and symptoms of PD patients. Therefore, appropriate behavioral assessments are extremely crucial for correctly understanding the mechanisms of PD and accurately evaluating the efficacy and safety of novel therapies. This article systematically reviews the behavioral assessments, for both motor and non-motor symptoms, in various animal models involved in current PD research. We addressed the strengths and weaknesses of these behavioral tests and their appropriate applications. Moreover, we discussed potential mechanisms behind these behavioral tests and cautioned readers against potential experimental bias. Since most of the behavioral assessments currently used for non-motor symptoms are not particularly designed for animals with PD, it is of the utmost importance to greatly improve experimental design and evaluation in PD research with animal models. Indeed, it is essential to develop specific assessments for non-motor symptoms in PD animals based on their characteristics. We concluded with a prospective view for behavioral assessments with real-time assessment with mobile internet and wearable device in future PD research.
Copyright © 2016 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Behavioral assessments; Fine motor; Food reaching movement; Free-moving counting; Locomotion motor symptoms; Neuropsychological tasks; Non-motor symptoms; Parkinsonian model

Mesh:

Year:  2016        PMID: 27026638     DOI: 10.1016/j.neubiorev.2016.03.016

Source DB:  PubMed          Journal:  Neurosci Biobehav Rev        ISSN: 0149-7634            Impact factor:   8.989


  19 in total

Review 1.  Current behavioral assessments of movement disorders in children.

Authors:  Tetsuya Asakawa; Kenji Sugiyama; Takao Nozaki; Tetsuro Sameshima; Susumu Kobayashi; Liang Wang; Zhen Hong; Shu-Jiao Chen; Can-Dong Li; Ding Ding; Hiroki Namba
Journal:  CNS Neurosci Ther       Date:  2018-07-24       Impact factor: 5.243

2.  Neuroprotective Effects of Temsirolimus in Animal Models of Parkinson's Disease.

Authors:  Rosalba Siracusa; Irene Paterniti; Marika Cordaro; Rosalia Crupi; Giuseppe Bruschetta; Michela Campolo; Salvatore Cuzzocrea; Emanuela Esposito
Journal:  Mol Neurobiol       Date:  2017-03-29       Impact factor: 5.590

Review 3.  A meta-analysis evaluating effects of the rotigotine in Parkinson's disease, focusing on sleep disturbances and activities of daily living.

Authors:  Weibo Sun; Qingyong Wang; Chuwen Feng; Tiansong Yang; Yuanyuan Qu; Yan Yang; Chaoran Li; Zhongren Sun; Tetsuya Asakawa
Journal:  Neurol Sci       Date:  2022-06-13       Impact factor: 3.830

Review 4.  Role of Parameter Setting in Electroacupuncture: Current Scenario and Future Prospects.

Authors:  Yuan-Yuan Zhang; Qi-Liang Chen; Qiong Wang; Shan-Shan Ding; Shu-Nan Li; Shu-Jiao Chen; Xue-Juan Lin; Can-Dong Li; Tetsuya Asakawa
Journal:  Chin J Integr Med       Date:  2020-07-20       Impact factor: 2.626

5.  N-palmitoylethanolamide Prevents Parkinsonian Phenotypes in Aged Mice.

Authors:  Rosalia Crupi; Daniela Impellizzeri; Marika Cordaro; Rosalba Siracusa; Giovanna Casili; Maurizio Evangelista; Salvatore Cuzzocrea
Journal:  Mol Neurobiol       Date:  2018-03-19       Impact factor: 5.590

Review 6.  The delta-opioid receptor and Parkinson's disease.

Authors:  Jin-Zhong Huang; Yi Ren; Yuan Xu; Tao Chen; Terry C Xia; Zhuo-Ri Li; Jian-Nong Zhao; Fei Hua; Shi-Ying Sheng; Ying Xia
Journal:  CNS Neurosci Ther       Date:  2018-08-03       Impact factor: 5.243

7.  Drug-induced Parkinson's disease modulates protein kinase A and Olfactory Marker Protein in the mouse olfactory bulb.

Authors:  Carla Mucignat; Antonio Caretta
Journal:  Behav Brain Funct       Date:  2017-01-26       Impact factor: 3.759

Review 8.  Evidence for the Use of Acupuncture in Treating Parkinson's Disease: Update of Information From the Past 5 Years, a Mini Review of the Literature.

Authors:  Fan Jiang; Tiansong Yang; Hongna Yin; Yuhuai Guo; Hiroki Namba; Zhongren Sun; Tetsuya Asakawa
Journal:  Front Neurol       Date:  2018-07-25       Impact factor: 4.003

9.  Dl-3-n-Butylphthalide Alleviates Behavioral and Cognitive Symptoms Via Modulating Mitochondrial Dynamics in the A53T-α-Synuclein Mouse Model of Parkinson's Disease.

Authors:  Huiying Li; Hongquan Wang; Ling Zhang; Manshi Wang; Yanfeng Li
Journal:  Front Neurosci       Date:  2021-05-28       Impact factor: 4.677

10.  Neuroprotective effect of neuroserpin in non-tPA-induced intracerebral hemorrhage mouse models.

Authors:  Wei Li; Tetsuya Asakawa; Sha Han; Baoguo Xiao; Hiroki Namba; Chuanzhen Lu; Qiang Dong; Liang Wang
Journal:  BMC Neurol       Date:  2017-11-07       Impact factor: 2.474

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.